Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in Atrial

Lena Rivard1, Paul Khairy1, Mario Talajic1

  • 1Department of Medicine, Université de Montréal, Montréal, Québec, Canada.

Insights

This study investigated if rivaroxaban reduces stroke and cognitive decline in atrial fibrillation (AF) patients. Results will clarify anticoagulation benefits for AF-related neurocognitive impairment.

Area of Science:

  • Cardiology
  • Neurology
  • Clinical Trials

Background:

  • Growing evidence links atrial fibrillation (AF) to cognitive decline and dementia.
  • Understanding AF's impact on brain health is crucial for preventative strategies.

Purpose of the Study:

  • To determine if rivaroxaban, an oral anticoagulant, reduces the risk of stroke, transient ischemic attack (TIA), or cognitive decline.
  • To evaluate the efficacy of anticoagulation in patients with nonvalvular AF and low stroke risk.

Main Methods:

  • The Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in Atrial Fibrillation (BRAIN-AF) is a prospective, multicentric, double-blind, randomized-controlled trial.
  • Patients with nonvalvular AF and low stroke risk were randomized to rivaroxaban (15 mg daily) or standard of care.
  • Exclusion criteria included high bleeding risk.

Main Results:

  • The primary outcome is a composite of stroke, TIA, and cognitive decline (defined as ≥ 3-point decrease in Montreal Cognitive Assessment score).
  • Approximately 3250 patients will be enrolled across 130 sites.
  • The study aims to reach 609 adjudicated primary outcome events.

Conclusions:

  • BRAIN-AF will provide critical data on the effectiveness of rivaroxaban in preventing adverse cerebrovascular and cognitive outcomes in AF patients.
  • Findings will inform clinical guidelines for managing AF to preserve cognitive function.
Abstract

Related Concept Videos

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
241
Blind Procedures02:07

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
13.2K
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
11.7K
Amyloid Fibrils03:03

Amyloid Fibrils

6.3K
Random Sampling Method01:09

Random Sampling Method

Sampling is a technique to select a portion (or subset) of the larger population and study that portion (the sample) to gain information about the population. Data are the result of sampling from a population. The sampling method ensures that samples are drawn without bias and accurately represent the population. Because measuring the entire population in a study is not practical, researchers use samples to represent the population of interest. Among the various sampling methods used by...
14.2K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.2K